Be Prepared to Switch Patients to New Fluticasone/Salmeterol Inhalers
New fluticasone/salmeterol inhalers for asthma (AirDuo, etc) will compete with Advair...and lead to questions about how to switch.
Teva is launching AirDuo (air-DOO-oh) RespiClick AND its generic, fluticasone/salmeterol, at the same time. The generic costs about $90/month...versus $285/month for AirDuo or up to $475/month for Advair.
But the new dry-powder inhalers are NOT generics for Advair Diskus because they come in different strengths and devices. Plus AirDuo is not approved for COPD...and it's only for ages 12 and up.